GDF15 therefore has been suggested as an auxiliary biomarker for the diagnosis and prognosis of various cancers, including lung cancer (Cai et al., 2020), for which a good correlation with clinical stage has been demonstrated (Deng et al., 2021). This evidence concerns the gene GDF15 and cancer.